Clarus Corporation reported Q4 2025 sales of $65.4 million, adjusted EBITDA of $1.2 million, and full year 2025 sales of $250.4 million with adjusted EBITDA of $1.1 million. The company provided 2026 guidance of $255-265 million in sales and $9-11 million in adjusted EBITDA, highlighting its debt-free balance sheet and simplification strategy.
Key takeaways
Q4 2025 sales $65.4 million vs $71.4 million same quarter prior year
Q4 2025 adjusted EBITDA $1.2 million (1.8% margin) vs $4.4 million (6.1% margin)
Full year 2025 sales $250.4 million vs $264.3 million in 2024
Full year 2025 adjusted EBITDA $1.1 million (0.4% margin) vs $6.9 million (2.6% margin)
2026 guidance: sales $255-265 million, adjusted EBITDA $9-11 million
Cash $36.7 million and total debt $0 as of December 31, 2025
Q4 free cash flow $11.6 million; full year outflow $9.9 million